Nikola Pantic
@kolja_pantic
Followers
176
Following
4K
Media
47
Statuses
415
internal medicine/hematology trainee🩺📚🩸Personal account. Opinions expressed are my own.
Belgrade, Republic of Serbia
Joined May 2021
Deep venous #thrombosis in patients with atresia of the inferior vena cava and right kidney hypoplasia (KILT syndrome): Systematic #review of the literature https://t.co/7fSVPX03gs
@drmmitrovic @VMJ_SVM
3
2
5
🌟 Upcoming career development webinar! Join us for a special ISTH–@EHA_Hematology Career Development Webinar: “Hematology Research – For Patients, With Patients” 🗓️ Don’t miss this opportunity to learn, connect and grow in your career: https://t.co/LjdrvFSGvh
1
6
15
Thank you so much for helping us raise awareness of ALL! #acutelymphoblasticleukemia
Today is World ALL Day! Supporting everyone affected by Acute Lymphoblastic Leukaemia – patients, families and loved ones. Together, we raise awareness and share hope.
0
1
1
🔴 September is #BloodCancerAwarenessMonth At EBMT, we join the global effort to increase public understanding of blood cancers and highlight the importance of early diagnosis. Through collaborative science and clinical expertise, we are committed to advancing research,
1
14
23
🩸🔍 Anticoagulation & Bone Marrow Biopsy – Is it safe? 📌 Background •BM biopsy = most common hematology diagnostic procedure. •Complication = bleeding (rare but potentially severe). •Effect of anticoagulation on bleeding risk = unclear. Guidelines = inconsistent . 📊
0
9
33
Original Article: Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO trial) https://t.co/Epe4Q957pV Editorial: Art within Evidence — Balancing Anticoagulant Duration in VTE Care https://t.co/IdJp3T20rM
#ESCCongress | @escardio
1
20
65
Presented at #ESCCongress: In patients with provoked venous thromboembolism and ongoing risk factors, extended treatment with low-dose apixaban for 12 months resulted in a lower risk of recurrent VTE than placebo, with a low risk of major bleeding. Full HI-PRO trial results:
0
80
193
New Special Issue in @IJMS_MDPI: Biomarkers for Precision Medicine in Cancer-Associated Thrombosis! Submit your work by 11/30/2025. Info here: [ https://t.co/p6Q2bbjPIy]
#cancerresearch #thrombosis #biomarkers
0
2
4
Immune thrombocytopenia (ITP) is an autoimmune disorder that causes low platelet counts. Curious about the cause of low platelets in ITP? Watch the video to learn more about the pathophysiology of this rare disease #ISTH2025. This is intended for US health care professionals.
0
3
6
Another successful and fruitful conference, another great 4 days... @EHA_Hematology is raising the standards higher and higher every year ☺️ #EHA2025 @antichematolog @lekovic13 @vladimirota
#EHA2025, it's a wrap! Thank you to all our delegates, faculty and partners for joining us in Milan for 3.5 days of learning and connection. We look forward to seeing you again next year in Stockholm from 11-14 June for #EHA2026. Save the date!
2
1
16
Hem/oncs carry not only their own burdens, but also the weight of their patients' and their families' struggles. It's not just making the diagnosis and treating by the protocols...it's understanding person across you, fighting for funds, for studies and loads of bureaucracy 💪🏻
#BurnoutSurvey among heme professionals 🚨 N=1843 42% high emotional exhaustion 33% high depersonalization 50% burnout 67% low personal accomplishment Systemic factors > personal resilience It’s time to act ! @EHA_Hematology @young_eha @Hemasphere_EHA
0
0
3
Screening for monoclonal gammopathy of undetermined significance is contraindicated https://t.co/sHoFTXxFMT
1
37
92
#EHA is a space for career growth, learning, and connection, and #YoungEHA sessions are no different. From addressing burnout to hematology in outer space, this year's sessions will bring you new perspectives from the field from June 12-15. Register now: https://t.co/BoqSsnFbGq
0
3
8
#EHA2025 is a unique career opportunity for early-career professionals to connect with the global hematology community. With a full-day YoungEHA Research Meeting program, Education Sessions, opportunities to network, and the latest clinical and research data this is your
0
2
8
Check out our new article in @JAMA_current! Practical advice on Factor V Leiden testing. https://t.co/j6qlVqHQ3N
jamanetwork.com
This JAMA Insights explores factor V Leiden, an inherited thrombophilia, and its association with venous and arterial thrombosis, how it affects pregnancy outcomes, and testing.
0
4
11
Share this graphic to show your support for #AMLWorldAwarenessDay! More “I'm supporting AML World Awareness Day” graphics are available at https://t.co/Lsj55K6sjx
#KnowAML
0
4
8
Final chance to register for our free one-hour webinar on respiratory viral infections in hematological patients. Taking place on April 22 at 16:00 (CEST), the webinar will feature Jon Salmanton Garcia, Chair of the EHA-SWG on Infections in Hematology, as the speaker. Register
0
5
8
I ❤️ imatinib I ❤️ venetoclax I ❤️ ATRA/ATO I ❤️ Rituximab I ❤️ PTCy 💪🏽
10
19
184
